Matthew brings extensive experience and relationships across global biotechnology and venture capital to the team, having been a partner of a national venture capital firm, CFO of a publicly-traded biotech, and CFO of a number of private life sciences companies.
Matthew is also Executive Vice President and Chief Financial Officer at adMare BioInnovations. Most recently, Mr. Carlyle was the Chief Financial Officer of Viable Healthworks Corp., and from 2004 to 2013, was Chief Financial Officer of Allon Therapeutics Inc. Previously, he served in Corporate Finance and Development roles for a number of public and private life science and technology companies and has been involved in raising approximately $200M. Mr. Carlyle is a founding Partner of NDI Capital, a private investment management company focused on investing in high potential life science and healthcare companies.
He holds the Chartered Financial Analyst designation and is a member of the Association for Investment Management and Research and the Vancouver Society of Financial Analysts